Laurence Gladieff

Laurence Gladieff

UNVERIFIED PROFILE

Are you Laurence Gladieff?   Register this Author

Register author
Laurence Gladieff

Laurence Gladieff

Publications by authors named "Laurence Gladieff"

Are you Laurence Gladieff?   Register this Author

54Publications

1395Reads

7Profile Views

Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing.

Int J Cancer 2019 04 13;144(8):1962-1974. Epub 2018 Nov 13.

Inserm, Paris, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.31921
Publisher Site
http://dx.doi.org/10.1002/ijc.31921DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587727PMC
April 2019

Prognostic impact of celiac lymph node involvement in patients after frontline treatment for advanced ovarian cancer.

Eur J Surg Oncol 2019 Feb 19. Epub 2019 Feb 19.

Department of Surgical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse (IUCT), Oncopole, Toulouse, France; INSERM CRCT 1, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejso.2019.02.018DOI Listing
February 2019

Follicular growth but absence of oocyte and cumulus maturation during ovarian stimulation in the days following surgical abortion: a case report.

Gynecol Endocrinol 2017 Sep 28;33(9):680-681. Epub 2017 Apr 28.

a Médecine de la Reproduction, CHU Toulouse , Toulouse , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09513590.2017.1320386DOI Listing
September 2017

Cancers de l’ovaire BRCA muté : consultation d’oncogénétique et prescription des inhibiteurs de PARP.

Bull Cancer 2017 May;104 Suppl 1:S16-S23

Département d'oncologie médicale, centre Léon-Bérard, 28, rue Laennec, 69008 Lyon et university Claude-Bernard, Lyon I, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0007-4551(17)30158-3DOI Listing
May 2017

[Germ cell tumor in adolescents and young adults].

Bull Cancer 2016 Dec 4;103(12):1057-1063. Epub 2016 Nov 4.

Institut d'hémato-oncologie pédiatrique, 1, place J.-Renaud, 69008 Lyon, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.10.005DOI Listing
December 2016

Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer.

J Clin Oncol 2016 12 23;34(36):4345-4353. Epub 2016 Oct 23.

Joyce F. Liu, Dana-Farber Cancer Institute, Boston; Isabelle Tabah-Fisch and Joseph Pearlberg, Sanofi Oncology; Victor Moyo, Kaveh Riahi, Rachel Nering, William Kubasek, Bambang Adiwijaya, Akos Czibere, and Gavin MacBeath, Merrimack Pharmaceuticals, Cambridge, MA; R. Wendel Naumann, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC; Robert L. Coleman, MD Anderson Cancer Center, Houston, TX; Isabelle Ray-Coquard, Centre Léon Bérard, University Claude Bernard, and Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Lyon; Frederic Selle, Hôpital Tenon and GINECO; Eric Pujade-Lauraine, Hôpital Hotel-Dieu, Université Paris Descartes, and GINECO, Paris; Laurence Gladieff, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse Oncopole, and GINECO, Toulouse, France; Andrés M. Poveda, Instituto Valenciano de Oncologia and Grupo Español de Investigación en Cáncer de Ovario (GEICO), Valencia; Josep Maria del Campo, Hospital Universitari Vall d'Hebron and GEICO, Barcelona, Spain; David Cibula, General University Hospital Prague and Charles University, Prague, Czech Republic; Hal Hirte, Hamilton Health Sciences-Juravinski Cancer Centre, Hamilton, Ontario, Canada; Felix Hilpert, Universitätsklinikum Schleswig-Holstein, Kiel; Philipp Harter, Kliniken Essen Mitte and Arbeitsgemeinschaft Gynäkologische Onkologie, Essen, Germany; Francesco Raspagliesi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori; Salvatore Siena, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, and Università degli Studi di Milano, Milano, Italy; and Ignace Vergote, University Hospital Katholieke Universiteit Leuven and Leuven Cancer Institute, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.1891DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562430PMC
December 2016

Chemotherapy-Related Reticulate Hyperpigmentation: A Case Series and Review of the Literature.

Dermatology 2015 1;231(4):312-8. Epub 2015 Oct 1.

Department of Dermatology, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000439047DOI Listing
August 2016

Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study.

J Clin Oncol 2016 Mar 11;34(7):706-13. Epub 2016 Jan 11.

Eric Pujade-Lauraine, Centre des Cancers de la Femme et Recherche Clinique, Paris; Frédéric Selle, Hôpitaux Universitaires de l'Est Parisien-site Tenon and Alliance Pour la Recherche En Cancérologie, Paris; Béatrice Weber, Centre Alexis Vautrin, Vandoeuvre-les-Nancy; Isabelle-Laure Ray-Coquard, Centre Léon Bérard and Université Claude Bernard-Lyon I, Lyon; Alain Lortholary, Centre Catherine de Sienne, Nantes; Anne Lesoin, Centre Oscar Lambret, Lille; Philippe Follana, Centre Antoine-Lacassagne, Nice; Gilles Freyer, Lyon University, Hospices Civils de Lyon, Pierre-Bénite Cédex; Laurence Gladieff, Institut Claudius Regaud-IUCTO, Toulouse; Mouna Sassi and Serge Nazabadioko, Boehringer Ingelheim, Reims; Florence Joly, Centre François Baclesse, Caen, France; Ignace Vergote, University Hospitals Leuven, KU Leuven, Leuven, Belgium; Jozef Sufliarsky, National Cancer Institute, Bratislava, Slovakia; Josep Maria Del Campo, Hospital University, Vall d'Hebrón; Beatriz Pardo, Institut Català d'Oncologia-Instituto de Investigación Biomédica de Bellvitge; Laura Vidal, Hospital Clínic de Barcelona, Barcelona, Spain; Bengt Tholander, Uppsala University Hospital, Uppsala, Sweden; Pilar Garin-Chesa, Boehringer Ingelheim, Vienna, Austria; Kristell Marzin, Boehringer Ingelheim, Biberach; and Korinna Pilz, Boehringer Ingelheim, Ingelheim, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.1474DOI Listing
March 2016

GENESIS: a French national resource to study the missing heritability of breast cancer.

BMC Cancer 2016 Jan 12;16:13. Epub 2016 Jan 12.

Inserm, U900, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-2028-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711059PMC
January 2016

[Nurse telephone support at home during chemotherapy].

Rev Infirm 2015 Aug-Sep(213):37-9

Institut Claudius Regaud, Institut universitaire du cancer de Toulouse Oncopole, 1, avenue Irène Joliot-Curie, 31059 Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.revinf.2015.06.011DOI Listing
December 2015

Vaginal reconstruction with pedicled vertical deep inferior epigastric perforator flap (diep) after pelvic exenteration. A consecutive case series.

Gynecol Oncol 2015 Sep 27;138(3):603-8. Epub 2015 Jun 27.

Department of Surgical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer, 1 av Joliot Curie, 31000 Toulouse Cedex 09, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.06.031DOI Listing
September 2015

Adherence to guidelines in gynecologic cancer surgery.

Int J Gynecol Cancer 2014 Nov;24(9):1675-8

*Department of Surgical Oncology; †Department of Medical Oncology; ‡Department of Surgical Pathology; §Department of Radiation Therapy; and ∥Department of Radiology, Institut Claudius Regaud, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000284DOI Listing
November 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S20-5

*Jikei University School of Medicine, Tokyo, Japan; †Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom; ‡Osaka University Graduate School of Medicine, Osaka, Japan; §Kyoto University Graduate School of Medicine, Kyoto, Japan; ∥Keio University, Tokyo, Japan; ¶Tottori University School of Medicine, Tottori, Japan; #National Defense Medical College, Saitama, Japan; **Clinical Research, Innovation, and Education Center, Tohoku University Hospital, Sendai, Japan; ††Sunnybrook Hospital, Toronto, Canada; ‡‡UCL Cancer Institute, London, United Kingdom; §§Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; ∥∥Border Medical Oncology, Victoria, Australia; ¶¶Department of Pathology, Glasgow Royal Infirmary, Glasgow, United Kingdom; ##Institute of Cancer Sciences, University of Glasgow Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, United Kingdom; ***Gynecologic Oncology Center, Kiel, Germany; †††National Cancer Center, Goyang, Korea; ‡‡‡Institut Claudius Regaud, Toulouse, France; §§§National Cancer Institute, Naples, Italy; and ∥∥∥Princess Margaret Hospital, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000289DOI Listing
November 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S90-5

*Saitama Medical University International Medical Center, Saitama, Japan (GOTIC); †Hyogo Cancer Center, Akashi, Japan (GOTIC); ‡Harvard Medical School, Boston, MA (RTOG); §Southern General Hospital, Glasgow, Lanarkshire, UK; ¶Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK (SGCTG); ∥Hospices Civils de Lyon, Lyon, France (GINECO); #Sunnybrook Regional Cancer Center, Toronto, Ontario, Canada (GOG); **Fondazione IRCCS National Cancer Institute of Milan, Milan, Italy (MITO); ††Kliniken Essen Mitte, Essen, Germany (AGO); ‡‡Seoul National University College of Medicine, Seoul, Korea (KGOG); §§Institut Claudius Regaud, Toulouse, France (GINECO); ¶¶Instituto Nazionale Tumori, Napoli, Italy (MITO); and ∥∥Prince of Wales Hospital, Sydney, Australia (ANZGOG).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000297DOI Listing
November 2014

Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?

Psychooncology 2014 Apr 11;23(4):420-7. Epub 2013 Oct 11.

INSERM, UMR912, Marseille, France; Aix-Marseille Université, UMR912, Marseille, France; IRD, UMR912, Marseille, France; McGill University, Montreal, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.3435DOI Listing
April 2014

Model-based approach to describe G-CSF effects in carboplatin-treated cancer patients.

Pharm Res 2013 Nov 26;30(11):2795-807. Epub 2013 Jun 26.

Unité de Médecine, Urgences Soins Intensifs, Université de Toulouse, INP, Ecole Nationale Vétérinaire de Toulouse, 31076, Toulouse, France,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11095-013-1099-zDOI Listing
November 2013

Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

Cancer Epidemiol Biomarkers Prev 2010 Nov 26;19(11):2859-68. Epub 2010 Oct 26.

Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-10-0517DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077716PMC
November 2010

The c.5242C>A BRCA1 missense variant induces exon skipping by increasing splicing repressors binding.

Breast Cancer Res Treat 2010 Apr 30;120(2):391-9. Epub 2009 Apr 30.

INSERM U563, Institut Claudius Regaud, 20-24 rue du Pont St Pierre, 31052, Toulouse, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-009-0392-3
Publisher Site
http://dx.doi.org/10.1007/s10549-009-0392-3DOI Listing
April 2010

[Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer].

Bull Cancer 2009 Dec;96(12):1243-52

Departement de Chirurgie Oncologique, EA3035, Departement d'Anatomo-Pathologie, Université de Toulouse, Departement d'Oncologie Médicale Institut Claudius-Regaud, 20-24 Rue du Pont-Saint-Pierre, 31052 Toulouse Cedex.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2009.1005DOI Listing
December 2009

A comparative study of laparoscopic extraperitoneal lymphadenectomy [correction of laparoscopy] with the use of ultrasonically activated shears.

Am J Obstet Gynecol 2009 Oct 9;201(4):370.e1-5. Epub 2009 Jul 9.

Department of Gynecologic Oncology, Institut Claudius Regaud, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2009.05.026DOI Listing
October 2009

Spontaneous regression of peritoneal carcinomatosis in a borderline ovarian tumour.

Eur J Obstet Gynecol Reprod Biol 2009 Jan 4;142(1):84-5. Epub 2008 Nov 4.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejogrb.2008.08.008DOI Listing
January 2009

[Preservation of fertility in gynaecologic cancers].

Bull Cancer 2008 May;95(5):487-94

Comité de gynécologie, Institut Claudius-Regaud, rue du Pont-Saint-Pierre, 31052 Toulouse.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2008.0619DOI Listing
May 2008

Pelvic lymph node dissection via a lateral extraperitoneal approach: description of a technique.

Gynecol Oncol 2008 Apr 7;109(1):81-5. Epub 2008 Feb 7.

Institut Claudius Regaud, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2007.12.031DOI Listing
April 2008